An assay procedure is presented using high-performance liquid chromatography and fluorescence detection for simultaneous determination of imipramine, desipramine, and their 2-hydroxylated metabolites in whole blood and various tissues of the rat. By modifying methods previously described for plasma, we have developed an assay method for sensitive, reproducible quantitation of these compounds in rat plasma, whole blood, brain, liver, and fetus. Increasing the volume of the extraction solvent (20% butanol in hexane) increased recovery of imipramine and desipramine to greater than 90% for all tissues examined. No interfering peaks were observed for any of the tissues studied. Addition of n-butylamine as a modifier to the mobile phase decreased the retention of all four compounds and decreased peak tailing of the demethylated compounds. The total elution time was less than 15 min. Using these methods the coefficient of variation for all four compounds was generally less than 5% for each of the five tissues examined. The calibration curves were linear for standard concentrations of 25–2,000 ng/ml spiked tissue homogenate. This method has sufficient sensitivity and specificity for use in pharmacokinetic studies of imipramine.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bickel MH, Weder HJ (1968) The total fate of a drug: Kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine. Arch Int Pharmacodyn Ther 173:433–463
DeVane CL, Jusko WJ (1981) Plasma-concentration monitoring of hydroxylated metabolites of imipramine and desipramine. Drug Intell Clin Pharm 15:263–266
Dingell JV, Sulser F, Gillette JR (1964) Species differences in the metabolism of imipramine and desmethylimipramine. J Pharmacol Exp Ther 143:14–22
Gram LF (1974) Metabolism of tricyclic antidepressants: A review. Dan Med Bull 21:218–228
Grime JK, Sexton ED (1982) Enthalpimetric study of the surface interactions of n-butylamine with silica gel. Anal Chem 54:902–907
Hammer WH, Brodie BB (1967) Application of isotope derivative technique to assay of secondary amines: Estimation of desipramine by acetylation with 3H-acetic anhydride. J Pharmacol Exp Ther 157:503–508
Jandhyala BS, Steenberg ML, Perel JM, Manian AA, Buckley JP (1977) Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dog. Eur J Pharmacol 42:403–410
Potter WZ, Calil HM, Manian AA, Zavadil AP, Goodwin FK (1979) Hydroxylated metabolites of tricyclic antidepressants: Preclinical assessment of activity. Biol Psychiatry 14:601–613
Risch SC, Huey LY, Janowsky DS (1979) Plasma levels of tricyclic antidepressants and clinical efficacy: Review of the literature. J Clin Psychiatry 40:4–16, 56–69
Suckow RF, Cooper TB (1981) Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection. J Pharm Sci 70:257–261
Sutfin TA, Jusko WJ (1979) High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites. J Pharm Sci 68:703–705
About this article
Cite this article
Stout, S.A., Lindsay DeVane, C. Quantification of imipramine and its major metabolites in whole blood, brain, and other tissues of the rat by liquid chromatography. Psychopharmacology 84, 39–41 (1984). https://doi.org/10.1007/BF00432021
- High-performance liquid chromatography (HPLC)
- Tricyclic antidepressants
- Tissue-drug concentrations